Announces topline results from REVEAL2, the second Phase 3 trial evaluating VGX-3100 as a treatment for cervical high-grade squamous intraepithelial lesions.
Kaneka injects $15m to up mRNA capacity - BioProcess Insider bioprocessintl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioprocessintl.com Daily Mail and Mail on Sunday newspapers.
INOVIO Provides an Update on Lassa Fever and MERS Programs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious.